The immunohistochemistry data in the HPA database reveal that the immunoreactive score (IRS) of SHPK was significantly higher in glioma tissues (both low- and high-grade gliomas) than in the normal cerebral cortex tissues (Figure 1D). The gene discussed is SHPK; the disease is central nervous system cancer.